Cure Alzheimer's Fund Cure Alzheimer's Fund

Gal Bitan, Ph.D.

Dr. Bitan’s laboratory focuses on developing new therapeutic and diagnostic tools for diseases related to protein misfolding and aggregation, particularly Alzheimer’s and Parkinson’s diseases. The laboratory synthesizes novel molecules and explores their potential for diagnostic and therapeutic uses. These efforts are guided by structural knowledge that is obtained though multifaceted, collaborative experimental and theoretical studies. The techniques and methodologies used in the laboratory are interdisciplinary in nature, ranging from peptide chemistry, through biochemistry and biophysics, to molecular, cell, and animal biology.

Dr. Bitan received both his B.S. and Ph.D. from The Hebrew University of Jerusalem, Israel.

Related Research:

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Optimization of Pharmacalogic Properties of Molecular Tweezers 2015

$100,000
Molecular Tweezers—Novel Inhibitors of Amyloidogenic Proteins and Promising Drug Candidates for Alzheimer’s Disease 2011

$100,000

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Attar A, Liu T, Chan WT, Hayes J, Nejad M, Lei K, Bitan G A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer’s disease, PLOS ONE, 8(11), November 13, 2013, Read More

Aida Attar, Cristian Ripoli, Elisa Riccardi, Panchanan Maiti, Domenica D. Li Puma, Tingyu Liu, Jane Hayes, Mychica R. Jones, Kristin Lichti-Kaiser, Fusheng Yang, Greg D. Gale, Chi-hong Tseng, Miao Tan, Cui-Wei Xie, Jeffrey L. Straudinger, Frank-Gerrit Klarner, Thomas Schrader, Sally A. Frautschy, Claudio Grassi and Gal Bitan Protection of primary neurons and mouse brain from Alzheimer’s pathology by molecular tweezers, Brain, A Journal of Neurology, doi:10.1093/brain/aws289, November 26, 2012, 3735-48, Read More

Back to Our Researchers